Screening programmes

Screening is offered proactively to defined groups who generally have no symptoms of the condition being screened for. An invitation reflects programme eligibility rather than suspicion. The programme includes every step from invitation to follow up, not only the screening test.

A screening programme is more than a test Screening uses a test or examination to identify apparently well people who have a higher chance of a particular condition or complication. The purpose is to improve outcomes or provide information that supports informed choices. A screening programme is the organised system surrounding that test. It includes identifying eligible people, sending invitations, providing information, performing the test, communicating results and arranging appropriate follow up. The programme also needs trained staff, reliable information systems, standards, safety checks and quality assurance. A test offered without this pathway is not automatically an organised screening programme. Population and targeted screening Population screening proactively offers screening to a group defined from the wider population, often using features such as age, sex or pregnancy. People generally do not have symptoms of the condition being screened for. Targeted screening proactively offers screening to a group with an above average risk. That increased risk may relate to past or current smoking, genetics, another health condition or another defined factor. Targeted screening is not the same as investigating symptoms. People with symptoms should enter the appropriate clinical assessment pathway rather than waiting for a screening invitation. A known condition does not always prevent screening A person may already have one diagnosis but still receive screening for a related complication. Diabetic eye screening is offered to people with diabetes to look for diabetic retinopathy before sight changes appear. The target condition is diabetic retinopathy, not diabetes itself. This example shows why apparently well refers to the condition being screened for rather than perfect health. Surveillance is different. Surveillance repeatedly monitors a known disease, abnormality or treatment risk as part of clinical care rather than screening an apparently unaffected group. Eligibility follows programme rules An eligible population is the group a programme intends to offer screening. Eligibility can depend on age, sex or anatomy, pregnancy, newborn status, a known condition or another risk factor. An invitation does not mean that a clinician suspects the person has the condition. It usually means that health records place them within the programme's eligibility rules. Records can be incomplete or use details that affect automatic invitations. If you think you are eligible but were not invited, contact the relevant screening service or your GP practice. Each UK country sets its own screening policy after considering UK National Screening Committee advice. The programmes, ages, intervals and implementation details can therefore differ across England, Scotland, Wales and Northern Ireland. Screening is a choice People offered screening should receive accessible and balanced information. This should explain the condition, testing process, possible benefits, harms, limitations, uncertainties and possible next decisions. Informed choice means deciding whether to accept or decline after receiving information you can understand. Accepting screening is not compulsory, and declining does not mean that you have acted irresponsibly. You can ask questions, request communication support or discuss the choice with a trained healthcare professional. Programme information should respect different values and circumstances. The screening pathway continues after the test A screening pathway is the route from identifying eligible people through invitation, testing, results and any onward referral. The exact steps differ between programmes. A screen positive result means the result places someone in a higher chance group or meets the programme's referral criteria. It does not usually confirm the condition by itself. The next step may be another test, specialist assessment, closer monitoring or treatment discussion. Some programmes also report unclear or inadequate results that require another sample or examination. A screen negative result means the test indicates a lower chance at that time. It does not guarantee that the condition is absent or that it cannot develop later. A later condition is not automatically a false negative A false negative occurs when the condition was present at the time of screening but the test did not identify it. A condition that genuinely develops after screening is not automatically a false negative. This distinction explains why some programmes invite people again after a defined interval. Risk can change, and one negative result does not provide lifelong reassurance. The next lessons examine screening results, test performance and overdiagnosis in more detail. This lesson focuses on how the programme itself is organised. Screening must produce more benefit than harm Finding more abnormalities is not enough to justify screening. The complete programme should improve health outcomes or support important informed choices while keeping harms proportionate. The UK National Screening Committee reviews evidence about the condition, test, intervention and whole programme. It also considers feasibility, acceptability, resources, equity and how the programme will be monitored. A condition may lack a screening programme because evidence does not show enough overall benefit. This does not mean that the condition is unimportant or that symptomatic people should not be investigated. Recommendations can change as tests, treatments and evidence change. A programme may be introduced, modified, targeted differently or withdrawn after review. Quality and equitable access matter Quality assurance means checking whether services meet agreed standards and improve when problems appear. It covers the pathway from identifying eligible people to referral and treatment where required. Programmes monitor invitation, uptake, test quality, result communication, referral and outcomes. Safety systems aim to prevent people being lost between stages. Equitable access means eligible people should have a fair opportunity to receive understandable information and complete screening. Services may need interpreters, accessible formats, longer appointments or other reasonable adjustments. Screening does not replace symptom assessment Do not wait for the next screening invitation if you develop symptoms. Screening intervals and tests are designed for people without symptoms of the target condition. Contact your GP practice or NHS 111 when symptoms need assessment. Follow any timeframe and contact instructions given in a screening result letter. This lesson explains general programme principles. It cannot determine whether you are eligible, interpret an individual result or replace the instructions from your local screening service.

A screening programme is a complete, quality assured pathway for a defined group. Eligibility creates an offer rather than a diagnosis, participation remains a choice and symptoms require a separate clinical assessment pathway.